The IPO provides significant capital for R&D and operations. Monitor upcoming 10-Q filings for how the company allocates these funds and whether they achieve key development milestones. The stock may experience volatility as it establishes a trading pattern.
Price Chart
Executive Summary
Alamar Biosciences completed its IPO, raising approximately $219.9 million by selling 12,937,500 shares at $17.00 per share. The company also amended its certificate of incorporation and bylaws in connection with the offering. This marks the company's transition to a public entity.
Key Facts
- Completed IPO on April 20, 2026
- Sold 12,937,500 shares at $17.00 per share
- Raised approximately $219.9 million in gross proceeds
- Filed amended and restated certificate of incorporation
- Adopted amended and restated bylaws
- Common stock now authorized: 1,000,000,000 shares
- Preferred stock authorized: 20,000,000 shares
Financial Impact
Raised $219.9 million in gross proceeds from IPO
Risk Factors
- Dilution from new share issuance
- Increased regulatory and reporting requirements as a public company
- Market volatility for newly public biotech stocks
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-163921 |
| Document: d103481d8k.htm | 0001193125-26-163921 |
| Document: 0001193125-26-163921-index-headers.html | 0001193125-26-163921 |
| Document: 0001193125-26-163921-index.html | 0001193125-26-163921 |
| Document: 0001193125-26-163921.txt | 0001193125-26-163921 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $31.93 (−16.45%) |
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $31.93 (−16.45%) |
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $31.93 (+16.45%) |
Oct 5, 2026 22d ago | Press Release | $32.26 | awaiting T+60 | — | $31.93 (−1.02%) |
Sep 24, 2026 4w ago | Press Release | $32.80 | awaiting T+60 | — | $31.93 (−2.65%) |
Sep 1, 2026 8w ago | 8-K | $30.49 | awaiting T+60 | — | $31.93 (+4.72%) |
Aug 10, 2026 11w ago | 8-K | $36.57 | awaiting T+60 | — | $31.93 (−12.69%) |
Jul 13, 2026 15w ago | Press Release | $27.40 $32.26 | ▲ +17.74% | ▲ +13.74% | $31.93 (+16.53%) |
Jul 10, 2026 15w ago | Press Release | $28.42 $38.13 | ▲ +34.17% | ▲ +31.53% | $31.93 (+12.35%) |
May 8, 2026 24w ago | 8-K | $23.96 $27.11 | ▲ +13.15% | ▲ +8.31% | $31.93 (+33.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers